论文部分内容阅读
目的:分析布地奈德联合沙丁胺醇吸入治疗急性加重期慢性阻塞性肺疾病患者(AECOPD)的效果。方法:选择该院2014年5月至2015年11月间收治的AECOPD患者60例作为研究对象,并随机分为观察组及对照组30例。对照组在常规治疗基础上给予沙丁胺醇雾化吸入治疗,观察组在常规治疗基础上给予布地奈德联合沙丁胺醇雾化吸入治疗,对比两组患者治疗效果。结果:观察组总有效率为90.0%;对照组总有效率为80.0%。观察组总有效率要高于对照组(P<0.05)。结论:布地奈德联合沙丁胺醇雾化吸入治疗AECOPD具有较好的效果,可有效控制患者病情,改善患者肺功能。
OBJECTIVE: To evaluate the efficacy of budesonide combined with salbutamol inhalation in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: Sixty AECOPD patients admitted to our hospital from May 2014 to November 2015 were selected as study subjects and randomly divided into observation group (30 cases) and control group (30 cases). The control group was given inhalation of salbutamol inhalation on the basis of conventional treatment. The observation group was treated with inhalation of budesonide combined with salbutamol inhalation on the basis of routine treatment, and the therapeutic effect was compared between the two groups. Results: The total effective rate was 90.0% in the observation group and 80.0% in the control group. The total effective rate in observation group was higher than that in control group (P <0.05). Conclusion: Budesonide combined with salbutamol nebulization for AECOPD has a good effect, which can effectively control the patient’s condition and improve the lung function.